RBC Capital Cuts Price Target on Moderna (NASDAQ:MRNA) to $190 From $200By legume / August 4, 2023 / Moderna, Royal Bank of Canada RBC Capital Cuts Price Target on Moderna (NASDAQ:MRNA) to $190 From $200, Maintains Outperform Rating.